Publications

5808 Results

Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group.

Authors
EL Sievers;FO Smith;WG Woods;JW Lee;WA Bleyer;CL Willman;ID Bernstein
Journal / Conference
Leukemia 9:2042-2048
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

NCAM-associated tumors: Are they a discrete group of disorders?

Authors
TP Miller;TM Grogan
Journal / Conference
Lymphoma Conference Program and Summaries-San Antonio Texas
Year
1995
Research Committee(s)
Lymphoma

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer.

Authors
WT Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;WJ Curran;RW Byhardt;AT Turrisi;AR Dar;J D Cox
Journal / Conference
Journal of the National Cancer Institute 87(3):198-205
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

RTOG 8808 ECOG 4588, Preliminary analysis of a phase III trial in regionally advanced unresectable non-small cell lung cancer with minimum three year follow-up.

Authors
WT Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;JD Cox;B Emami;WJ Curran;RW Byhardt;AR Dar;AT Turrisi
Journal / Conference
Int.l Journal of Radation Oncology Biology Phyics 32Suppl:195(#109)
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Response to induction chemotherapy does not predict for long term survival among patients with unresected stage III non-small cell lung cancer (NSCLC) receiving sequential chemo-radiation on RTOG 8804 and 8808.

Authors
WJ Curran;CB Scott;R Komaki;RW Byhardt;S Taylor;B Emami;CJ Langer;AR Dar;JS Cooper;EJ Andras;WT Sause
Journal / Conference
Int.l Journal of Radiation Oncology Biology Physics 32Suppl:196(#111)
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group study

Authors
CJ Fabian;CM Mansfield;S Dahlberg;SE Jones;TP Miller;E Van Slyck;PN Grozea;FS Morrison;CA Coltman, Jr;RI Fisher
Journal / Conference
Annals of Internal Medicine 120(11):903-912
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7808

Phase II trial of menogaril in metastatic adenocarcinoma of the prostate: A Southwest Oncology Group study.

Authors
SA Taylor;BA Blumenstein;RL Stephens;ED Crawford;B Pistone;JB Hill
Journal / Conference
Investigational New Drugs 12:67-70
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8509

A phase II evaluation of amonafide in advanced sarcoma: A Southwest Oncology Group study.

Authors
SS Buys;B Metch;SP Balcerzak;JR Neefe;WJ Stuckey
Journal / Conference
Cancer Investigation 12(4):399-402
Year
1994
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8715

Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: A Southwest Oncology Group study.

Authors
R Saez;S Dahlberg;FR Appelbaum;RJ Hartsock;F LeMaistre;CA Coltman Jr.;RI Fisher
Journal / Conference
Hematological Oncology 12(2):75-85
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8309

Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors: A Southwest Oncology Group study

Authors
V Gupta;EB Thompson;D Stock-Novack;SE Salmon;HI Pierce;JD Bonnet;D Chilton;J Beckord
Journal / Conference
Investigational New Drugs 12(2):121-128
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8530